1. Medicines and Healthcare products Regulatory Agency. The British Pharmacopoeia Commission. The British Pharmacopoeia Commission vol. I (2020).
2. The Royal Pharmaceutical Society. The British National Formulary. BNF vol. 79 (2020).
3. Kreutner, W. et al. Preclinical pharmacology of desloratadine, a selective and nonsedating histamine H1 receptor antagonist / 1st communication: Receptor selectivity, antihistaminic activity, and antiallergenic effects. Arzneimittel-Forschung/Drug Res. 50, 345–352 (2000).
4. Ashour, S. & Khateeb, M. Novel Kinetic Spectrophotometric Method Using Sodium 1,2-Naphthoquinone-4-Sulphonate for Determination of Desloratadine in Pharmaceutical Formulations. J. Pharm. Qual. Assur. 1, 16–24 (2015).
5. A Sensitive Spectrophotometric Method for the Determination of Desloratadine in Tablets